Biomarkers of Pathological Response on Neo-Adjuvant Chemo-Immunotherapy Treatment for Resectable Stage IIIA NSCLC Patients

被引：8

作者：

Laza-Briviesca, R. ^{[1
]}

Cruz-Bermudez, A. ^{[1
]}

Casarrubios, M. ^{[1
]}

Nadal, E. ^{[2
]}

Insa, A. ^{[3
]}

Garcia Campelo, R. ^{[4
]}

De Dios Alvarez, N. ^{[5
]}

Domine, M. ^{[6
]}

Majem, M. ^{[7
]}

Rodriguez-Abreu, D. ^{[8
]}

Calvo De Juan, V. ^{[1
]}

Martinez-Marti, A. ^{[9
,10
]}

De Castro Carpeno, J. ^{[11
]}

Cobo, M. ^{[12
]}

Lopez-Vivanco, G. ^{[13
]}

Del Barco, E. ^{[14
]}

Bernabe, R. ^{[15
]}

Vinolas, N. ^{[16
]}

Barneto, I. ^{[17
]}

Viteri, S. ^{[18
]}

Massuti, B. ^{[19
]}

Provencio, M. ^{[1
]}

机构：

[1] Hosp Univ Puerta de Hierro Majadahonda, Inst Invest Sanitaria Puerta de Hierro Majadahond, Serv Oncol Med, Madrid, Spain

[2] Inst Catala Oncol, Med Oncol, Barcelona, Spain

[3] Hosp Clin Univ, Clin Fdn Incliva, Valencia, Spain

[4] Hosp Univ A Coruna, La Coruna, Spain

[5] Hosp Univ Vigo, Pontevedra, Spain

[6] Hosp Fdn Jimenez Iis Fjd, Madrid, Spain

[7] Hosp La Santa Creu & St Pau, Barcelona, Spain

[8] Hosp Insular Gran Canaria, Las Palmas Gran Canaria, Spain

[9] Vall Dhebron Univ Hosp, Barcelona, Spain

[10] Inst Oncol Vhio, Barcelona, Spain

[11] Hosp Univ La Paz, Madrid, Spain

[12] Univ Hosp Reg Malaga, Malaga, Spain

[13] Hosp Univ Cruces, Baracaldo, Spain

[14] Hosp Univ Salamanca, Salamanca, Spain

[15] Hosp Univ Virgen Del Rocio, Seville, Spain

[16] Clin Hosp, Oncol, Barcelona, Spain

[17] Hosp Univ Reina Sofia, Cordoba, Spain

[18] Hosp Univ Quiron Dexeus, Inst Oncol Dr Rosell, Grp Quironsalud, Barcelona, Spain

[19] Hosp Gen Alicante, Alicante, Spain

来源：

JOURNAL OF THORACIC ONCOLOGY | 2019年 / 14卷 / 10期

关键词：

stage IIIA NSCLC; biomarkers; neo-adjuvant chemo-immunotherapy;

D O I：

10.1016/j.jtho.2019.08.1515

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

P2.04-10

引用

页码：S711 / S711

页数：1

共 50 条

[1] Immune cell biomarkers on neo-adjuvant chemo-immunotherapy treatment for resectable stage IIIA NSCLC patients
Laza-Briviesca, R.
Cruz-Bermudez, A.
Casarrubios, M.
Nadal, E.
Insa Molla, M. A.
Garcia-Campelo, M-R.
Huidobro, G.
Domine Gomez, M.
Majem Tarruella, M.
Rodriguez Abreu, D.
Martinez-Marti, A.
De Castro Carpeno, J.
Cobo Dols, M.
Lopez Vivanco, G.
del Barco Morillo, E.
Bernabe, R.
Vinolas, N.
Barneto Aranda, I. C.
Massuti Sureda, B.
Provencio, M.
ANNALS OF ONCOLOGY, 2019, 30
[2] Haematological biomarkers of pathological response on neo-adjuvant chemo-immunotherapy treatment for resectable stage IIIA non-small cell lung cancer (NSCLC) patients.
Laza Briviesca, Raquel
Cruz Bermudez, Alberto
Barquin, Miguel
Nadal, Ernest
Insa, Amelia
Garcia-Campelo, Rosario
De Dios Alvarez, Noemi
Domine, Manuel
Massuti, Bartomeu
Majem, Margarita
Rodriguez-Abreu, Delvys
Martinez Marti, Alex
Cobo, Manuel
Lopez-Vivanco, Guillermo
del Barco, Elvira
Bernabe, Reyes
Vinolas, Nuria
Barneto, Isidoro
Viteri, Santiago
Provencio-Pulla, Mariano
JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
[3] TMB and Selected Mutations in Resectable Stage IIIA NSCLC Patients Receiving Neo-Adjuvant Chemo-Immunotherapy from NADIM Trial
Cruz-Bermudez, A.
Casarrubios, M.
Briviesca, R. Laza
Nadal, E.
Insa, A.
Mosquera, J.
Huidobro, G.
Domine Gomez, M.
Massuti, B.
Majem Tarruella, M.
Rodriguez-Abreu, D.
Martinez-Marti, A.
De Castro Campeno, J.
Cobo Dols, M.
Lopez Vivanco, G.
Del Barco, E.
Bernabe Caro, R.
Vinolas, N.
Barneto, I.
Viteri, S.
Jove, M.
Romero, A.
Franco, F.
Provencio, M.
JOURNAL OF THORACIC ONCOLOGY, 2021, 16 (03) : S543 - S543
[4] Predictive molecular parameters of pneumonitis development in stage IIIa NSCLC patients treated with neo-adjuvant chemo-immunotherapy from NADIM clinical trial
Sierra-Rodero, B.
Garitaonaindia, Y.
Martinez-Cutillas, M.
Nadal, E.
Insa, A.
Garcia Campelo, M. R.
Casal Rubio, J.
Domine Gomez, M.
Majem Tarruella, M.
Rodriguez Abreu, D.
Martinez-Marti, A.
De Castro Carpeno, J.
del Barco, E.
Vinolas, N.
Barneto Aranda, I. C.
Massuti Sureda, B.
Casarrubios, M.
Laza-Briviesca, R.
Cruz-Bermudez, A.
Provencio, M.
JOURNAL OF THORACIC ONCOLOGY, 2021, 16 (04) : S740 - S740
[5] Neo-adjuvant chemo/immunotherapy for the treatment of resectable stage IIIA non-small cell lung cancer (NSCLC): A phase II multicenter exploratory study" NADIM trial
Calvo de Juan, V.
Insa Molla, A.
Cobo Dols, M.
Massuti Sureda, B.
Lopez-Vivanco, G.
Casal Rubio, J.
de Castro, J.
Majem Tarruella, M.
Bernabe Caro, R.
Gonzalez-Larriba, J.
Barneto Aranda, I. C.
Nadal, E.
Martinez Marti, A.
Vinolas Segarra, N.
Guillot Morales, M.
Vicente Baz, D.
Camps Herrero, C.
Domine Gomez, M.
Rodriguez Abreu, D.
Provencio Pulla, M.
ANNALS OF ONCOLOGY, 2017, 28
[6] Randomized Controlled Study Comparing Adjuvant versus Neo-Adjuvant Chemotherapy in Resectable Stage IB to IIIA NSCLC
Yang, Xue-Ning
Zhong, Wen-Zhao
Ben, Xiao-Song
Luo, Hong-He
Wang, Changli
Wang, Qun
Qiao, Guibin
Yan, Hong-Hong
Wu, Yi Long
JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (01) : S277 - S278
[7] Trial in progress: NEO-adjuvant chemo-IMmunotherapy in PAnCreaTic cancer-NEO-IMPACT
Maloney, S.
Tebbutt, N.
Nikfarjam, M.
Samra, J.
Mendis, S.
Tie, J.
Christopherson, L.
Hayes, S.
Berthon-Jones, N.
Yim, C. H. H.
El-Omar, E.
Chantrill, L.
ANNALS OF ONCOLOGY, 2023, 34 : S922 - S922
[8] Peripheral blood T-cell receptor immune repertoire characterization of resectable stage IIIA non-small cell lung cancer patients receiving neo-adjuvant chemo-immunotherapy treatment from NADIM study.
Cruz Bermudez, Alberto
Casarrubios, Marta
Laza Briviesca, Raquel
Sierra-Rodero, Belen
Barquin, Miguel
Romero, Atocha
Franco, Fernando
Calvo, Virginia
Nadal, Ernest
Insa, Amelia
Garcia-Campelo, Rosario
Casal, Joaquin
Domine, Manuel
Massuti, Bartomeu
Majem, Margarita
Rodriguez-Abreu, Delvys
Martinez-Marti, Alex
De Castro, Javier
Provencio-Pulla, Mariano
JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
[9] TUMOR RESPONSE AND TOXICITY IN NEO-ADJUVANT ERLOTINIB IN EARLY STAGE NSCLC PATIENTS
Schaake, Eva E.
Klomp, Houke M.
Burgers, J. A.
JOURNAL OF THORACIC ONCOLOGY, 2011, 6 (06) : S387 - S388
[10] Adjuvant chemo-immunotherapy after curative resection of stage II and IIIA primary lung cancer
Kimura, H
Yamaguchi, Y
LUNG CANCER, 1996, 14 (2-3) : 301 - 314

← 1 2 3 4 5 →